Overview

Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide

Status:
RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the incidence of early post-traumatic seizures. The study will also assess the benefit of lacosamide compared to levetiracetam in regards to agitation and behavioral adverse effects in patients with moderate to severe traumatic brain injury requiring seizure prophylaxis.
Phase:
PHASE4
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Lacosamide
Levetiracetam